2023 Speakers
Esam Abualrous, Schrodinger
Chris Adams, Chief Executive Officer, Andarix Pharmaceuticals
Milos Aleksic, Senior Director, Drug Discovery, Immunocore Ltd
Jennifer Altomonte, Founder & CSO, Fusix Biotech
Pep Amengual-Rigo, Senior Data Scientist, Sanofi-Aventis
Özlem Anak, Vice President, Global Programme Head, Cell & Gene, Novartis
Ian Anderson, Global Senior Principal Scientist in Analytics, Lonza
Paul Arras, Scientist, Merck KGaA
Mayanka Asthana, Senior Scientist, Astrazeneca
David Ausländer, Sr Principal Scientist, NIBR
Sameer Awsare, Managing Director, Kaiser Permanete
Samuel Azuz, Clinical Pharmacologist MD and Senior Registrar, Aalborg University Hospital
Barbara Bachler-Konetzki, Group Leader, Evotec
Francesca Barone, CSO, Candel Therapeutics
Fabio Baschiera, Global Clinical Leader - Ophthalmology, Bayer
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Philip Beer, Chief Scientific Officer, Step Pharma
Nicola Beltraminelli, VP, Chief Development Officer, INNATE PHARMA
Jannick Bendtsen, CEO, PipeBio
Martin Bertschinger, Deputy Cell Sciences Director, Ichnos Sciences
Oren Beske, Senior Vice President, ATUM Bio
Simone Bido, Researcher, IRCCS Ospedale San Raffaele
Mascha Binder, Head of Medical Oncology, University Hospital Basel
Phil Bland-Ward, Chief Development Officer, Crescendo Biologics Ltd
Bernd Bodenmiller, Dual Professor, University of Zurich & ETH Zurich
Sara Bonetti, Scientist, Salipro Biotech AB
Ezio Bonvini, CSO, Macrogenics
Louis Boon, Chief Scientific Officer and Board member JJP Biologics, JJP Biologics
Laure Bouchez, CSO, Worgpharma c/o Innovation Park Basel
Frederic Bouder, Professor Of Risk Management, University of Stavanger
Caroline Boulliat, md, Genchrome
Andrew Bradbury, CSO, Specifica, a Q2 Solutions Company
Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche
David Brockwell, Associate Professor, University of Leeds
Thomas Broge, Associate Director, Immunology, SeromYx Systems, Inc
Jack Brydon, KTP Associate, The University of Edinburgh
Tina Buch, Principal Scientist, Novartis
Vered Caplan, Chief Executive Officer, Orgenesis Inc
Sara Carillo, Applications Development Team Leader, Nibrt
Anders Carlsson, Founder & CSO, Bionamic
JP Carralot, director of biology, Brightpeak
Samuele Cazzamalli, Group Head of Small Molecule, Philochem
Patrick Chames, Team Leader, INSERM
Mariya Chernyavska, PhD candidate, Radboudumc
Andre Choo, Deputy Executive Director, Bioprocessing Technology Institute
Mimi Choon-Quinones, Founder & Board Chairman, Partners For Patients NGO
Sam Cooper, Co-Founder, Phenomic AI
Pierre Cordelier, Research Director, INSERM
Kristina Cornish, Partner, Pinsent Masons LLP
Elisa Corsiero, Post Doc Fellow, William Harvey Research Institute
Cristina Costa Santini, Senior Principal Scientist - Disease Modeller - Oncology, Roche
Andrew Creese, Associate Director, Analytical Development, Immunocore Ltd
Silvia Crescioli, Consultant, The Antibody Society
Catia Crespo, Director - Product Management Software, Refeyn
Christelle Dagoneau, SVP, Global Biologics Business Development, Just - Evotec Biologics
Marc Davies, VP, R&D, Leucid Bio
Anne De Groot, Chief Executive Officer, EpiVax Inc
Jansenn de Guzman, Lead Scientist, Development Services • Characterisation 1, Lonza Inc
Remco De Haas, Director, Commercial Division, Samsung Bioepis
Roberto De Luca, Senior Scientist, Philochem
Fernando De Mora, Professor of Pharmacology, Universitat Autònoma de Barcelona
Guy De Roo, Principal Scientist, Byondis
Joe de Rutte, Chief Executive Officer, Partillion Bioscience
Carmen De Santo, Cruk New Investigator Fellow, University of Birmingham
Emmanouil Dermitzakis, VP and Head of Computational Biology, GSK
Elie Dheilly, Principal scientist, Ichnos Biociences
Jonathan Didier, Senior Field Applications Scientist, Bruker
Achim Doerner, Associated Director, Antibody Discovery & Protein Engineering, Merck KGaA
Georg Dorn, Account Manager, Cytiva
Cyrille Dreyfus, Associate Director, Head of Protein Science, Ichnos Sciences
Nadjia DRICI, Global head of Biosimilars IT, Biogen
Dana Duey, Director, Antibody Discovery, Ablexis and AlivaMab Discovery Services
Paul Dunne, Business Development Specialist, Research Center Pharmaceutical Engineering Gmbh
Paul Dyer, Applications Scientist, Halo Labs Ltd
Michael Dyson, VP, Ichnos Sciences Biotherapeutics SA
Hilmar Ebersbach, SVP Antibody Development & Protein Engineering, ImmunOS Therapeutics
Roy Ehling, Research Scientist, Engimmune
Desislava Elter, Senior Scientist - Antibody Discovery and Engineering & Cell Assay Development, Merck KGaA
Kristofer Eriksson, CTO, MAGic Bioprocessing former Lab on a Bead
Patrick Farber, Principal Scientist, AbCellera
Mourad Farouk Rezk, Global Head Of Medical And Regulatory, Biosimilars, Biogen
Matthias Feige, Technical University Munich
Nora Fekete-Drimusz, Teamlead Biolab, LPKF Arralyze
Nadia Fernandez, Industry Clinical Collaboration Lead, F. Hoffmann-La Roche Ltd.
Mathieu Ferrari, Senior Director binder discovery, Autolus Ltd
Maria Fiammetta Romano, Prof, University of Naples Federico II
Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics
Jens A Fischer, Program Manager (Large Molecule Research) for Immunology, Infectious Diseases & Rare Blood Disorders, Roche
Adriano Flora, Director, The Jackson Laboratory
Paulo Fontoura, Global Head and SVP Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases, F. Hoffmann-La Roche Ltd
Linnea Franssen, Senior M&S Scientist, Roche
Johan Fransson, Executive Director Antibody and Protein Therapeutics, Prometheus Biosciences
Julian Freen-van Heeren, Lead Scientist Cellular & Antibody Effector Mechanism Assays, Sanquin Health Solutions
Tim Fugmann, CSO and Co-founder, Alithea Bio
Shilpa Gadgil, Head CDMO Development, Enzene Biosciences Ltd
Valentina Garrapa, Chief Executive Officer, Preclinics Italia
Andres Gassert, Director, Former Dicrector at STADA, Observa
Sreekanth Gattu, Global Program Head/Medical Director, Sandoz
Mathias Gehrmann, Head of Assays 2, Bayer
Cecile Geuijen, CSO, Merus
Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University
Jing Gong, Inside Sales Manager, Sino Biological Europe GmbH
Dimitrios Goundis, CBO, Exacis Biotherapeutics
Christoph Grapentin, Associate Principal Scientist, Lonza Group Ltd
Torbjorn Graslund, Professor, K.T.H. Royal Institute of Technology
Russell Green, Director of Product Growth, Automata
Per Greisen, Director for Computational Drug Discovery, Novo Nordisk
Matthew Greving, VP Head of Machine Learning and Platform Technologies, iBio
Francois Griaud, Senior Manager, Novartis Pharma AG
Simona Grieco, Associate Director Market Access, Biogen International GmbH
Ingrid Grunert, Scientist Mass Spectrometry (Pharma Technical Development, Analytics and Quality Control), Roche
Uwe Gudat, Chief Medical Officer, Aretaeus sàrl
Anna Lisa Guendner, Senior Lead Non-clinical Development - Cell Therapy Combination Products, Affimed GmbH
Tea Gunde, Chief Research Officer, Numab Therapeutics AG
Thomas Hach, ED, Novartis
Karin Hägerbrand, Director, Discovery Biology, Alligator Bioscience AB
Livnat Halel, Senior Clinical Projects Manager, Cerebral Therapeutics
Eric Halioua, President & Chief Executive Officer, PDC*line pharma SA
Eliott Harfouche, Partner, Nodes Advisors
Liu Hengshuo, Technique support specialist, Acrobiosystems
Kathrin Herbst, Director of Science and Business Development, Lightcast Discovery
Oscar Hernandez Alba, Research Assistant, Centre Nationale de Rechercher Scientifique (CNRS)
Jana Hersch, Head of Scientific Engagement, Genedata
Oliver Hill, Chief Scientific Officer, TriCos Biotherapeutics
Fabian Holenstein, Principal Scientist I, Novartis Institutes for BioMedical Research
Soraya Hölper, Project Lead for Portfolio and Strategy, Sanofi - Biologics Research
Fabian Hosp, Senior Scientist, Roche
Dean Houston, European Patent Attorney, Fresenius Kabi SwissBioSim
Thomas Huber, VP Discovery, Ridgeline Discovery
Nick Hutchinson, Business Steering Group Lead for Mammalian Cell Culture, Fujifilm Diosynth Biotechnologies
Roman Irsiegler, Global Biosimilars Team Lead, Pfizer
Melita Irving, Group Leader T-Cell Engineering, University of Lausanne
Karim Enrique Jaen Chavez, Technology Developer, Eversyn-Max Planck Institute
David James, Professor, University of Sheffield
Ruediger Jankowsky, Chief Executive Officer, AATec Medical GmbH
Rubin Jiang, Director of Nanjing Antibody Process Development and MSAT, Genscript Probio
Zoë Johnson, CSO, Affivant Sciences GmbH
Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)
Hélène Kaplon, Translational and Clinical Research Project Leader in Immunology, Servier
Nora Kaup, Project Lead Drug Substance, Novartis Pharma AG
Hans Keirstead, Chairman, Immunis Inc.
Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.
Kirsteen Keith, Director of Manufacturing and Outsourcing, Immunocore Ltd
Hubert Kettenberger, Head of Computational Protein Engineering, Roche
Riyaz Khan, Scientist I, ETH Zurich
Ana Kitanovic, Research assistant, ETH Zurich WiNS
Christian Klein, Dept Head, Roche Pharmaceutical Research and Early Development
Rinse Klooster, Director Early Antibody Discovery, Merus N.V., Merus B.V.
Marianna Koga, Senior Scientist, Tigen Pharma
Alex Koglin, Chief Executive Officer, NTx
Isabel Kolinko, Digital Transformation and Data Analytics Manager, Genedata AG
Leonie Kolmar, PhD student, École Polytechnique Fédérale de Lausanne (EPFL)
Harald Kolmar, Head of department applied biochemistry, TU Darmstadt Biochemie
Judith Krens, partner, Pinsent Masons Netherlands LLP
Dan Bach Kristensen, Principal Scientist, Symphogen
Felix Kuhne, Process Development Scientist, Roche
Dinesh Kundu, CEO& Co-founder, East Ocyon Bio
Leo Kunz, Principal Scientist, Roche Glycart AG
Vincent Larraillet, Science and Matrix Lead, Roche Diagnostics GmbH
Mayra Latorre-Martinez, Clinical Study Assessor, Swissmedic
Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel
Alexandra Lavoisier, Principal Scientist I, Novartis Institutes for BioMedical Research
Gabrielle Leclercq, Scientist, Roche Glycart
Vivian Lee, Senior Research Scientist, Gilead Sciences
Jason Lehmann, Product Marketing Manager, Telesis Bio
Steve Lehrer, MD, SBLehrer LLC
Mengyao Li, Senior Expert, Novartis
Yi "Alex" Li, PhD, VP, Head of Antibody Discovery, XtalPi
Britta Lipinski, PhD Candidate – Antibody Discovery and Protein Engineering Merck KGaA, Merck Healthcare KGaA
Xin Liu, Group Leader, Sphere Fluidics Ltd
Ting Liu, Senior Medical Director, F. Hoffmann-La Roche Ltd
Stephen Lock, MDM, sciex
Sudarshan Reddy Lokireddy, Chief Executive Officer, Oncosimis Biotech Pvt Ltd
Séverine Lorrain, Senior Research Technician, University of Lausanne
Robin Löving, CSO, Salipro Biotech AB
Maria Lteif, Instructor, Paris Saclay University
Patrick Maeder, Head of Assay Development & Validation, Bioassay - A Reaction Biology Company
Bernard Maillere, Head of laboratory, CEA
Michela Manni, Senior Scientist, GlycoEra
Martina Marauli, Director Clinical Supply Innovation, MSD Innovation & Development GmbH
Paolo Marcatili, Principal Scientist, Novo Nordisk
Benoît Marchal, Founder, PicAps
Julie Marechal-Jamil, Biosimilars Policy & Science, Medicines for Europe
Estelle Marrer-Berger, Chief Development Officer, 3T Biosciences
Andrea Marschall, Postdoctoral, Technical University of Braunschweig
Karolina Marzantowicz, Chief Executive Officer, Modica
Paul Matejtschuk, Section Head Formulation Science, MHRA
Aïda Meghraoui, CEO, AMKbiotech
Domenico Merante, Global Clinical Development Therapeutic Area Clinical Lead Nephrology & Orphan/Rare Diseases, CSL Vifor
Simone Mester, Chief Executive Officer, Authera
Enkelejda Miho, Dean and Professor, University of Applied Sciences Northwestern Switzerland
Michel Mikhail, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent
Paul Monnier, Scientific Solutions Consultant, Benchling
Sara Montagner, Principal Scientist, Novartis Institutes for BioMedical Research
Emma Morris, Global Product Leader, Advanced Instruments
Michael Muenzberg, Business Development Officer, Rotterdam Biologics B.V.
Matthias Müllner, Founder, bespark*bio
Hafsah Nabi, Resident Doctor, Region Hovedstaden
Alessio Nahmad, Co-Founder, Tabby Therapeutics
Dario Neri, Co-Founder, Philogen; Department Of Chemistry And Applied Biosciences, Swiss Federal Institute of Technology Zurich
Sarfaraz Niazi, PROFESSOR, University of Illinois
Cecil Nick, Vice President (Technical), Parexel
Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D
Sharon Nijjar, Senior Scientist, LifeArc
Miroslav Nikolov, Senior scientist, Roche
Ahuva Nissim, prof, Queen Mary University
Haneen Njoum, Senior Data Scientist, Sanofi
Sebastian Oehler, Research Scientist, Philochem
Benjamin Oestringer, Principal Scientist, Immunocore Ltd
Aline Oliveira, Competitive Intelligence Analyst, Institute of Technology on Immunobiologicals (Bio-Manguinhos)
Felipe Opazo, Group Leader & CTO, Nanotag Technology
Christian Orlik, Associate Director In vitro Biology, Heidelberg Pharma Research GmbH
Rachel Owen, Vice President, Immunology - Proposal Services and Support, Precision for Medicine
Saban Özipek, Research Associate, Roche
Lukas Paciorkowski, CTO & Co-Founder, Modica
Neha Pant, Global Program Lead, Pieris Pharmaceuticals
Joseph Park, Senior Manager - RA, Samsung Bioepis
Nishma Patel, Health Economist, University College London
Ravish Patel, Senior Scientist, Sun Pharma
Lauri Peil, Key Account and Technology Officer, Icosagen
Dilara Perver, Junior Group Leader & Lecturer, ETH Zürich
Mark Petersen, Senior Scientist, Zymeworks
Simon Plyte, CSO, Biomunex Pharmaceuticals
Ned Pojskic, Vice President, Pharmacy Benefits Management, Greenshield Insurance Brokers LLC
Birgitte Klindt Poulsen, Head Of Department, Ass.Professor, Dept ClinicalPharmacology, University Hospital of Aarhus, Denmark
Philipp Probst, Associate Director ADC Research, Araris Biotech AG
Adam Pruška, postdoctoral researcher, ETH Zurich
Mateusz Putyrski, Senior Scientist, New Technologies, Bio-Rad
Steve Quayle, VP Translational Pharmacology, Cue Biopharma
Jean-Edouard Rabier, Business Development Director Gx Biological Solutions, Gerresheimer
Moutih Rafei, Chief Scientific Officer, Defence Therapeutics
Tobias Rainer, Senior associate Pharma Technical Development, Roche Diagnostics GmbH
Vidhya Ramamurthy, Director, Business Development, OmniAb
Alexander Rau, Scientist Protein Engineering, Anaveon
Anne-Sophie Rebstock, Senior Director, Head of Medicinal Chemistry, Vincerx Pharma
Rogier Reijmers, Principal Scientist, LUMICKS
Tracey Roberts, Senior Associate, Pinsent Masons
Johan Rockberg, Associate Professor, KTH
Ben Roediger, Lab Head, Immunology, NOVARTIS
Giulia Rotta, PhD student, Philochem
Volker Rudolph, Founder, Medrepo
Nicolas Sabarth, Research Laboratory Head in Biotherapeutics Discovery and Cancer Immunology, Boehringer-Ingelheim
Sreedhar Sagi, Head, Medical Affairs International Region, Sandoz (Novartis)
Rune Salbo, Head of Protein and Antibody Engineering, Orion corporation
Stefano Sammicheli, Director, Ichnos Sciences
Massimo Domenico Sammito, Computational Biologics Design - Associate Principal Scientist, AstraZeneca
Ken Savin, CSO, Redwire
Ulrike Scheffler, Senior Director Business Developer, FyoniBio
Simone Schmitt, Senior Director Antibody Development, Memo Therapeutics AG
Jan Schnitzer, Chief Executive Officer, P.R.I.S.M.
Fabian Schuette, Commercial Business Development Manager, Gerresheimer
Evelien Schurgers, Associate Director of Research, Worg Pharmaceuticals
Gregory Segala, CEO, FluoSphera
Jonathan Seidel, Expert Sience & Technology, Novartis Pharma AG
Andreas Seidl, CSO, Formycon AG
Monika Sekelja, Associate Director, Head of Bioinformatics, Nykode
Anita Seshire, Operations Manager - Targeted mRNA Delivery, Merck Healthcare KGaA
Caibin Sheng, Scientist, Deep Learning, GV20 Therapeutics
Leah Sibener, Co-Founder, Head of Therapeutic Discovery, 3T Biosciences
Jay Sinha, Director, Biologics CMC Development and Manufacturing, Celldex Therapeutics
Darko Skegro, Senior Investigator, Novartis Institutes for BioMedical Research
Dimitris Skokos, Executive Director, Cancer Immunology, Regeneron Pharmaceuticals
Jae Sly, Chief Business Development Officer, Obatala Sciences
Marc Smith, Director of Strategic Solutions, IDBS
Molly Smith, Cell Engineer, SYNGENSYS
Andreu Soldevila, Chief Executive Officer, SYNA therapeutics
Dayn Sommer, Director, BD and Alliance Management, Similis Bio
Vanita Sood, SVP, Head of Drug Discovery Research, Fable Therapeutics
Oliver Spadiut, Co-Founder and Scientific Advisor, NovoArc
Frank Staal, Professor of Molecular Stem Cell Biology, Leiden University Medical Center (Netherlands)
Krzysztof Stawujak, VP Sales Drug Development Europe & Asia, Selvita
Andreas Stengl, Team Lead, Protein Engineering, Ludwig Maximilians University Munich
Peter Stenico, Global Head, Biosimilars, Sandoz
Lars Stoeckl, Division Manager Service, FyoniBio
Sonja Stoelzle-Feix, Director of Scientific Affairs, Nanion Technologies
Marc Stroet, Postdoctoral researcher, Vrije Universiteit Brussel
Sertan Sukas, CEO, Innofluidics
Siret Tahk, Senior scientist, Icosagen
Jian Tang, Associate Professor, H.E.C. Montreal
Lorenz Tanner, Member of Patient Board, SAKK Swiss Group for Clinical Cancer Research
Nazanin Tatari, Post-Doctoral Fellow, University Hospital Basel
Ingrid Teige, VP of Preclinical Research, BioInvent International A.B.
Michael Thiele, Founder and Chief Scientific Officer, OncoOne Research & Development GmbH
Thomas Thoma, Head Clinical Trial Supply, Teva Pharmaceuticals
Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions
Kristin Thompson, VP, Chief Operating Officer, eurekare
John Tomtishen, Vice President of Operations, Cellares
Elisabetta Traggiai, Executive Director, Mechanistic Immunology, Novartis
Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society
Wala Turkistani, Head of ATMPs, Saudi Food and Drug Authority
Matthew Turner, Head government affairs Europe, ROW, Fresenius Kabi
Jens Twellmeyer, Associate Director Science & Technology, Novartis AG
Katharina Urban, Senior Scientist, Panosome
Stefanie Urlinger, Chief Scientific Officer, Cimeio Therapeutics
Timo van den Berg, Senior Director Immuno-Oncology, Byondis
Hans Van Der Vliet, Chief Scientific Officer And Senior Vice President, LAVA Therapeutics
Ellen van Geffen, Project Team Leader, IPA (ImmunoPrecise Antibodies)
Rali Vaskova, Head of Operations, FindMeCure
Perla Vega, Sales and Applications Specialist, Refeyn
Joey Verdi, CSO, Panosome
Alain Vertes, Managing Director, NxR Biotechnologies GmbH
Ana Luiza Vivan, strategic partnership manager, Fundação Butantan
Annette Vogl, VP, Biology and Translational Research, Tubulis GmbH
Bjørn Gunnar Voldborg, Director Cell Line and Protein Production Facility, Danish Technical University
Michael von Forstner, Global Head, Patient Safety and Pharmacovigilance Biosimilars, Biogen
Giuliana Vozza, Senior Scientist, Astrazeneca
Meenu Wadhwa, Section Leader For Cyotkines And Growth Factors Section, MHRA
ELSA WAGNER, Senior Scientist, Pierre Fabre
Janelle Waite, Director of Cancer Immunology, Regeneron Pharmaceuticals
Ruizhi Wang, CEO/Founder, Abselion
Ronnie Wei, Head of Biologics Discovery and Development, ModeX Therapeutics
Andreas Weise, Senior Account Manager, Genovac Antibody Discovery
Mathias Wenes, Head of Immunotherapy, MPC Therapeutics
Juergen Wieland, Global Drug Development Environmental Sustainability Lead, Novartis
Uwe Wittenberg, Director of Health Informatics, Merck KGaA
Séverine Wollenschneider, Patient Advocate and Clinical Trials Expert, Independent
Natascha Wuillemin, Executive VP Immunology, Mabylon AG
Timo Wulfmeyer, Senior Business Development Manager, SCHOTT Pharma AG & Co. KGaA
David Yadin, Senior Scientist, Alchemab Therapeutics
Alison Young, Associate Director, Cell Line Development, Fujifilm Diosynth Biotechnologies
Jared Young, Director, Biosimilar Strategy, Similis Bio
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Ping Zhang, Field Application Specialist, NanoTemper Technologies
Peipei Zhong, Director of Business Development, Sanyou Biopharmaceuticals Co. Ltd.
Xi Zhou, Computational Oncology, Research and Early Development, AbbVie
Stefan Zielonka, Associate Director, Protein Engineering And Antibody Technologies, Merck KGaA
Alla Zilberman, Vice President, Technical Marketing, Cygnus Technologies Inc
Iwan Zimmermann, Chief Operating Officer, Linkster Therapeutics AG
Maya Zlatanova, Chief Executive Officer, FindMeCure Ltd.
Tabea Zubel, Senior Scientist, Solvias AG
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events